Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-35
Closed -$1.02K 1422
2025
Q3
$1.02K Hold
35
﹤0.01% 1325
2025
Q2
$1.04K Hold
35
﹤0.01% 1450
2025
Q1
$1.07K Hold
35
﹤0.01% 1432
2024
Q4
$1.39K Hold
35
﹤0.01% 1476
2024
Q3
$1.36K Buy
+35
New +$1.42K ﹤0.01% 1478

Other funds holding SRDX

Whittier Trust's SRDX Position: Q4 2025 in Review

Whittier Trust sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 35 shares — an estimated $1.02K sold.

Whittier Trust first reported a position in SRDX in Q3 2024 and held it in 5 quarters. The position peaked at $1.39K in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Whittier Trust reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Whittier Trust sold 35 Surmodics shares in Q4 2025, an estimated $1.02K.
  • Whittier Trust first reported a position in Surmodics in Q3 2024 and held it in 5 quarters.
  • Whittier Trust's Surmodics position peaked at $1.39K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Whittier Trust's 13F filing for Q4 2025, filed 26 Jan 2026.